The goal of this study is to evaluate a digital chronic disease self-management program designed to provide virtual support and guidance for patients with type 2 diabetes.
Approximately 45% of patients with type 2 diabetes do not achieve adequate glycemic control (A1C \< 7%). When diabetes is uncontrolled, complications develop that threaten health and endanger life. This study will make an effort to address this growing health challenge and to reduce the burden of diabetes in this population. More broadly, this study will have important implications and benefits for the growing diabetes population in the U.S. Study results will inform future interventions to reduce diabetes and improve outcomes. A better understanding of the efficacy of a digital chronic disease self-management program will directly benefit the participants of the program but, in the future, has the potential to more broadly benefit this population throughout the nation.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
27
Digital delivery of a DSMES program designed to build self-management skills and support diabetes management. Recipients have access to online curriculum, a live CDCES, group-based communication forums, and connected technology to track weight, food intake, physical activity and glucose levels.
Palo Alto Medical Foundation Research Institute
Palo Alto, California, United States
Change in HbA1c at 6 months from baseline
Non-fasting venous blood sample
Time frame: Baseline, 6 months
Change in weight at 6 months from baseline
Percentage of body weight loss
Time frame: Baseline, 6 months
Change in medication adherence at 6 months from baseline
The Adherence Estimator, a three-item self-report questionnaire, will be used to assess medication adherence
Time frame: Baseline, 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.